Sneha Girap (Editor)

Sandra Saouaf

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Nationality
  
American

Occupation
  
immunologist


Years active
  
1995-present

Name
  
Sandra Saouaf

Sandra Saouaf

Other names
  
Sandra Jerrold-Jones, Sandra J. Saouaf

Employer
  
Bristol-Myers Squibb GlaxoSmithKline University of Pennsylvania Atlantic Bio Sci, LLC

Alma mater
  
Rutgers University, University of Pennsylvania

Sandra Saouaf is an American immunologist who researches autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes, multiple sclerosis and others.

Contents

Biography

Sandra Jerrold-Jones obtained a BA from Rutgers College in biology and went on to earn a PhD in Immunology from the University of Pennsylvania. After completion of her degree, Saouaf went to work in the cell signaling laboratory of Bristol-Myers Squibb where she completed her post doctorate fellowship. She then worked briefly at GlaxoSmithKline before returning to the University of Pennsylvania. Saouaf left the university and began a consulting business with pharmaceutical and biotechnical companies, hoping to help speed the process of discoveries for drugs to treat autoimmune disease. In 2012, together with University of Pennsylvania colleagues, she "discovered a possible treatment approach...through oral drugs" and founded Atlantic Bio Sci, LLC. In 2013, she won a Fellowship from the Alliance of Women Entrepreneurs.

Selected works

  • Weiner, D B; Williams, W V; Siegel, R M; Jerrold-Jones, S, et. al. (January 1989). "Molecular characterization of suppressor T cells". Transplantation Proceedings. 20 (6): 1151–1153. 
  • Siegel, Richard M; Katsumata, Makoto; Komori, Shinji; Jerrold-Jones, Sandra, et. al. (December 1990). "Mechanisms of Autoimmunity in the Context of T-Cell Tolerance: Insights from Natural and Transgenic Animal Model Systems". Immunological Reviews. 118 (1): 165–192. doi:10.1111/j.1600-065X.1990.tb00816.x. 
  • Saouaf, Sandra J; Mahajan, Sandeep; Rowley, R Bruce; Kut, Stephanie A, et. al. (September 1994). "Temporal Differences in the Activation of Three Classes of Non-Transmembrane Protein Tyrosine Kinases Following B-Cell Antigen Receptor Surface Engagement". Proceedings of the National Academy of Sciences of the United States of America. 91 (20): 9524–9528. doi:10.1073/pnas.91.20.9524. 
  • Saouaf, Sandra J; Kut, Stephanie A; Fargnoli, Joseph; Rowley, R Bruce, et. al. (1995). "Reconstitution of the B cell antigen receptor signaling components in COS cells". The Journal of Biological Chemistry. Baltimore, Maryland: American Society for Biochemistry and Molecular Biology. 270 (45): 27072–8. PMID 7592958. doi:10.1074/jbc.270.45.27072. 
  • Saouaf, Sandra J; Brennan, Patrick J; Shen, Yuan; Greene, Mark I. (December 2003). "Mechanisms of peripheral immune tolerance: Conversion of the immune to the unresponsive phenotype". Immunologic Research. 28 (3): 193–199. doi:10.1385/ir:28:3:193. 
  • Iacono, Kathryn T.; Brown, Amy L.; Greene, Mark I.; Saouaf, Sandra J. (December 2007). "CD147 Immunoglobulin Superfamily Receptor Function and Role in Pathology". Experimental and Molecular Pathology. 83 (3): 283–295. doi:10.1016/j.yexmp.2007.08.014. 
  • Saouaf, Sandra J; Brennan, Patrick J; Shen, Yuan; Greene, Mark I. (October 2009). "Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis". Experimental and Molecular Pathology. 87 (2): 99–104. doi:10.1016/j.yexmp.2009.06.003. 
  • References

    Sandra Saouaf Wikipedia